Users Coming Off Anti-Obesity Injections Regain Weight Far More Rapidly Compared to People Using Diet and Exercise

New research indicates that individuals who discontinue new slimming jabs like semaglutide or tirzepatide tend to recover reduced body mass at a significantly accelerated pace than those who stop conventional diet and exercise programs.

Research printed in a leading health publication demonstrates that while overweight people often shed substantial amounts of their total mass while undergoing treatment, the mass comes back at an estimated rate of nearly a kilo each month after stopping.

"Individuals using such medications should be cognizant of the danger of fast rebound weight gain when the treatment ends," warns researcher Dr. Susan Jebb.

That rate of regain suggests a return to pre-treatment mass in about 18 months.

Comparing Treatments

The analysis, which examined dozens of studies involving thousands of patients, compared the effects of GLP-1 agonists with other pills.

The team note that individuals who shed pounds through lifestyle changes alone typically see a more gradual creep back—perhaps 100 grams monthly—post-intervention.

Understanding the Rapid Regain

Nutrition scientists suggest the mechanism of the jabs explains the accelerated weight return.

The injections imitate a body's own chemical called GLP-1, which helps regulate feelings of fullness.

"Artificially providing GLP-1 levels far above than the body's typical production could lead to the body to generate a reduced amount of its endogenous GLP-1, and may also reduce responsiveness to its effects," said Dr. Adam Collins, a dietetics expert.

"Withdrawal of this GLP-1 'fix' means hunger is uncontrolled, making binge eating much more probable."

A Chronic Condition?

Health authorities advise the injections for people with obesity-related health risks, alongside prescribed lifestyle changes.

A number of clinicians contend that, due to the high risk of weight regain, the therapy should be considered life-long.

This perspective is reinforced by pharmaceutical companies, who say that the findings "emphasize the persistent nature of excess weight," similar to managing diseases like diabetes.

Patient Testimonies

People who have discontinued the jabs report a intense resurgence of cravings.

"It was like a switch activating and you're instantly ravenous," described an individual.

This challenge is compounded if users have not adopted sustainable dietary or behavioural modifications during therapy.

Growing Use

Survey data indicate that a significant number of adults in the UK have tried these injections in the last 12 months, with desire being substantial.

• Use is more common among women than men.
• The middle-aged demographic shows the highest usage rates.
• A large proportion access the medications through private prescriptions rather than public health services.

In conclusion, researchers stress that while the jabs are effective tools for shedding pounds, they are not a permanent cure and lasting health benefits hinges on combined lifestyle changes.